Reddig S, Minnema A M, Tandon R
University of Michigan Medical Center, Ann Arbor 48109-0120.
Ann Clin Psychiatry. 1993 Mar;5(1):25-7. doi: 10.3109/10401239309148920.
Clozapine is an atypical neuroleptic drug that was initially thought not to cause neuroleptic malignant syndrome (NMS). We report a case of NMS associated with clozapine as a single agent that developed in a patient with no prior history of NMS. In contrast to other reported cases of NMS with clozapine monotherapy in which rigidity was reported to be absent, our patient had classic NMS with lead-pipe rigidity. NMS should be included in the differential diagnosis of a febrile patient with a history of any neuroleptic treatment, including clozapine.
氯氮平是一种非典型抗精神病药物,最初被认为不会引起抗精神病药物恶性综合征(NMS)。我们报告一例与氯氮平单药治疗相关的NMS病例,该病例发生在一名既往无NMS病史的患者身上。与其他报道的氯氮平单药治疗导致NMS的病例不同,那些病例中未报告有强直,而我们的患者出现了伴有铅管样强直的典型NMS。对于有任何抗精神病药物治疗史(包括氯氮平)的发热患者,鉴别诊断时应考虑NMS。